SUITABILITY OF A NETWORK META-ANALYSIS OF TARGETED SYNTHETIC OR BIOLOGIC THERAPY FOR PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS DESPITE BIOLOGIC DMARDS

被引：0
|
作者：
Peterson, S. [1 ]
Alfonso-Cristancho, R. [2 ]
Pacou, M. [3 ]
Belhadi, D. [3 ]
Van Sanden, s [4 ]
Webb, T. [1 ]
Ganguly, R. [5 ]
Kurrasch, R. [5 ]
Rao, R. [6 ]
Hsu, B. [1 ]
Popik, S. [1 ]
Jansen, J. P. [7 ]
机构：
[1] Janssen Res & Dev LLC, Spring House, PA USA
[2] GlaxoSmithKline Res & Dev Ltd, Collegeville, PA USA
[3] Amaris, Paris, France
[4] Janssen Hlth Econ & Market Access EMEA Stat & Mod, Beerse, Belgium
[5] GlaxoSmithKline, Collegeville, PA USA
[6] GSK Med Res Ctr, Stevenage, Herts, England
[7] Precis Hlth Econ, Oakland, CA USA
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 05期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PMS6
引用
收藏
页码：A141 / A141
页数：1
相关论文
共 50 条
  • [31] Network Meta-Analysis of Targeted Immunomodulators in the Treatment of Psoriatic Arthritis Patients without Prior Biologic Treatment
    Strand, Vibeke
    Husni, M. Elaine
    Griffith, Jenny
    Song, Yan
    Singh, Rakesh
    Zhao, Jing
    Betts, Keith A.
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [32] Risk of Lung Cancer in Veterans with Rheumatoid Arthritis in Relation to Use of Conventional versus Biologic or Targeted Synthetic DMARDs
    Singh, Namrata
    Peterson, Alexander
    Baraff, Aaron
    Wysham, K.
    England, Bryant
    Baker, Joshua
    Smith, Nicholas
    Mikuls, Ted R.
    Weiss, Noel
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 879 - 881
  • [33] Network Meta-Analysis of Targeted Immunomodulators in the Treatment of Biologic-NaiVe Psoriatic Arthritis
    Strand, Vibeke
    Husni, M. Elaine
    Singh, Rakesh
    Betts, Keith
    Song, Yan
    Griffith, Jenny
    Ganguli, Arijit
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [34] Fusion proteins of biologic agents in the treatment of rheumatoid arthritis (RA) A network meta-analysis
    Wu, Mingcai
    Tao, Mengjun
    Wang, Quanhai
    Lu, Xiaohua
    Yuan, Hui
    MEDICINE, 2021, 100 (24) : E26350
  • [35] ARE BIOLOGIC AND TARGETED SYNTHETIC DMARDS SAFE TO USE IN PATIENTS WITH RENAL IMPAIRMENT?
    Rees, F.
    Jasim, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 560 - 560
  • [36] Drug Survival of JAK Inhibitors and Biologic DMARDs in Rheumatoid Arthritis Patients
    Chow, Jocelyn
    Sraka, Gabrielle
    Chau, Kristie
    Soucy, Elaine
    Chow, Andrew
    JOURNAL OF RHEUMATOLOGY, 2022, 49 (07) : 797 - 798
  • [37] EFFECT OF BODY MASS INDEX ON TREATMENT RESPONSE OF BIOLOGIC-/TARGETED SYNTHETIC DMARDS IN PATIENTS WITH RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS AND AXIAL SPONDYLOARTHRITIS
    Gialouri, C. G.
    Pappa, M.
    Evangelatos, G.
    Nikiphorou, E.
    Fragoulis, G. E.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1698 - 1698
  • [38] Ultrasound Evaluation of the Efficacy of Biologic and Targeted Synthetic Dmards Toward Rheumatoid Arthritis Patients: Kyushu Multicenter Rheumatoid Arthritis Ultrasound Prospective Observational Cohort in Japan
    Nishino, Ayako
    Kawashiri, Shin-ya
    Kawakami, Atsushi
    Yoshitama, Tamami
    Eiraku, Nobutaka
    Matsuoka, Noki
    Ueki, Yukitaka
    Okada, Akitomo
    Hamada, Hiroaki
    Hidaka, Toshihiko
    Nagano, Shuji
    Tsuru, Tomomi
    Fujikawa, Keita
    Arinobu, Yojiro
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [39] BIOLOGIC DMARDS IN PATIENTS WITH RHEUMATOID ARTHRITIS ON A SPANISH REGISTRY: PREDICTORS OF THERAPY DISCONTINUATION DUE TO REMISSION
    Hernandez, M. V.
    Gomez-Puerta, J. A.
    Canete, J. D.
    Gomez-Reino, J. J.
    Sanmarti, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 464 - 465
  • [40] SYNOVIAL MAST CELLS AND RESPONSES TO SYNTHETIC AND BIOLOGIC DMARDS IN EARLY AND ESTABLISHED RHEUMATOID ARTHRITIS
    Rivellese, F.
    Nerviani, A.
    Mauro, D.
    Pagani, S.
    Humby, F.
    Pitzalis, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 900 - 901
12345